Ketoconazole inhibits oxidative modification of low density lipoprotein
- 7 April 1995
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 114 (1) , 9-18
- https://doi.org/10.1016/0021-9150(94)05456-s
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Does superoxide radical have a role in macrophage-mediated oxidative modification of LDL?Atherosclerosis, 1993
- Modified forms of low density lipoprotein and atherosclerosisAtherosclerosis, 1993
- The participation of nitric oxide in cell free- and its restriction of macrophage-mediated oxidation of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
- Modification of thein vitroCytotoxicity of Hydrogen Peroxide by Iron ComplexesFree Radical Research Communications, 1992
- Cytochrome P450 enzymes: ubiquitous "receptors" for drugsCanadian Journal of Physiology and Pharmacology, 1991
- CHEMIEXCITATION IN THE ARACHIDONIC ACID CASCADEPhotochemistry and Photobiology, 1991
- Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoproteinAtherosclerosis, 1990
- Lucigenin-dependent chemiluminescence in mononuclear phagocytes. Role of superoxide anionScandinavian Journal of Clinical and Laboratory Investigation, 1987
- Co-oxidation of luminol by hypochlorite and hydrogen peroxide implications for neutrophil chemiluminescenceBiochemical and Biophysical Research Communications, 1985
- Specificity of Medicarpin and Related Isoflavonoids in Inhibition of Rat Hepatic Mixed Function Oxidase ActivityPharmacology, 1985